M. Granatkin, E. Nikitin, M. Kislova, E. Mikhailov, V. Doronin, S. Minenko, M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. Pochtar, S. A. Lugovskaya, Y. Kobzev, V. Ptushkin, E. Rimashevskaya
{"title":"低甲基化药物联合BCL-2抑制剂治疗复发性急性髓性白血病:S.P. Botkin医院经验","authors":"M. Granatkin, E. Nikitin, M. Kislova, E. Mikhailov, V. Doronin, S. Minenko, M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. Pochtar, S. A. Lugovskaya, Y. Kobzev, V. Ptushkin, E. Rimashevskaya","doi":"10.17650/1818-8346-2023-18-1-12-19","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":36905,"journal":{"name":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience\",\"authors\":\"M. Granatkin, E. Nikitin, M. Kislova, E. Mikhailov, V. Doronin, S. Minenko, M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. Pochtar, S. A. Lugovskaya, Y. Kobzev, V. Ptushkin, E. Rimashevskaya\",\"doi\":\"10.17650/1818-8346-2023-18-1-12-19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":36905,\"journal\":{\"name\":\"Klinicheskaya Onkogematologiya/Clinical Oncohematology\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicheskaya Onkogematologiya/Clinical Oncohematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/1818-8346-2023-18-1-12-19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicheskaya Onkogematologiya/Clinical Oncohematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1818-8346-2023-18-1-12-19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience